“…All studies ( table 2 ) were published between 2009 and 2019 and undertaken in Australia 13–15 (n=3), Canada 16–22 (n=7), England 23–31 (n=9), Italy 32 (n=1), the Netherlands 33 (n=1), New Zealand 34 (n=1), Nigeria 35 (n=1), Spain 36 (n=1), Sweden 37 38 (n=2), USA 39–49 (n=11) and Wales 50 (n=1). Studies included CYP with the following LTCs: asthma (n=7), type 1 diabetes (n=5), chronic kidney disease (n=3), cancer (n=3), obesity (n=3), cerebral palsy/spina bifida (n=2), attention deficit hyperactivity disorder (ADHD) (n=2) and HIV, idiopathic scoliosis, colorectal conditions, chronic fatigue syndrome/myalgic encephalitis with n=1 study each.…”